IFN-γ and IL-1β treated-human placenta-derived mesenchymal stromal cells enhance the generation of IL-10 + T cells by upregulating PDLs expressions and ameliorate experimental autoimmune encephalomyelitis

Zhuoya Wang; Zhuoya Wang; Weiwei Wang; Weiwei Wang; Yun Hou; Yun Hou; Aiping Zhang; Aiping Zhang; Guoyan Wang; Guoyan Wang; Junzhu Yi; Junzhu Yi; Qiang Fu; Qiang Fu; Xiying Luan; Xiying Luan

doi:10.18632/oncotarget.24092

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/09/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

IFN-γ and IL-1β treated-human placenta-derived mesenchymal stromal cells enhance the generation of IL-10⁺T cells by upregulating PDLs expressions and ameliorate experimental autoimmune encephalomyelitis

Zhuoya Wang, Zhuoya Wang, Weiwei Wang, Weiwei Wang, Yun Hou, Yun Hou, Aiping Zhang, Aiping Zhang, Guoyan Wang, Guoyan Wang, Junzhu Yi, Junzhu Yi, Qiang Fu, Qiang Fu, Xiying Luan _ and Xiying Luan _

Zhuoya Wang1,* Weiwei Wang1,*, Yun Hou2, Aiping Zhang1, Guoyan Wang3, Junzhu Yi1, Qiang Fu1 and Xiying Luan1,4

1 Department of Immunology, Binzhou Medical University, Shandong Province, Yantai, People’s Republic of China

2 Department of Histology and Embryology, Binzhou Medical University, Shandong Province, Yantai, People’s Republic of China

3 Department of Laboratory, Affiliated Yantai hospital of Binzhou Medical University, Yantai, People’s Republic of China

4 Taishan Scholar Immunology program, Binzhou Medical university, Yantai, Shandong Province, People’s Republic of China

* Theses authors contributed equally to this work

Correspondence to:

Xiying Luan, email: [email protected]

Keywords: mesenchymal stromal cells (MSCs); IL-10+T cells; experimental autoimmune encephalomyelitis (EAE); PDLs; IFN-γ

Received: November 09, 2017 Accepted: January 02, 2018 Epub: January 09, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24092

Publication Alerts

Withdrawal Notice

Research Papers:

IFN-γ and IL-1β treated-human placenta-derived mesenchymal stromal cells enhance the generation of IL-10+T cells by upregulating PDLs expressions and ameliorate experimental autoimmune encephalomyelitis

IFN-γ and IL-1β treated-human placenta-derived mesenchymal stromal cells enhance the generation of IL-10⁺T cells by upregulating PDLs expressions and ameliorate experimental autoimmune encephalomyelitis